These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2575984)

  • 1. Efficacy of epanolol versus metoprolol in angina pectoris. Results from the Swedish Multicenter Study of Exercise Tolerance. The Swedish Multicenter Study Group.
    Rydén L
    Drugs; 1989; 38 Suppl 2():66. PubMed ID: 2575984
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative multicentre study of the tolerability and efficacy of epanolol versus metoprolol in patients with stable angina pectoris.
    Clark-Turner N
    Drugs; 1989; 38 Suppl 2():55-60. PubMed ID: 2575982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of epanolol versus metoprolol in angina pectoris: report from a Swedish multicentre study of exercise tolerance.
    Rydén L
    J Intern Med; 1992 Jan; 231(1):7-11. PubMed ID: 1346268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular function during treatment with either metoprolol or epanolol.
    Evans T
    Drugs; 1989; 38 Suppl 2():70. PubMed ID: 2575986
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of a long term multicentre study in Sweden.
    Boberg J
    Drugs; 1989; 38 Suppl 2():45. PubMed ID: 2575980
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative multicentre study of the tolerability and efficacy of epanolol versus nifedipine in patients with stable angina pectoris.
    Readman AS
    Drugs; 1989; 38 Suppl 2():61-5. PubMed ID: 2575983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and statistical methodology for the VISA studies.
    Ratcliffe MJ; Godley MJ
    Drugs; 1989; 38 Suppl 2():50-4. PubMed ID: 2575981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose finding in angina--results with epanolol.
    Omland TM; von Brandis C; Abrahamsen AM
    Drugs; 1989; 38 Suppl 2():35-8. PubMed ID: 2575978
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of epanolol and metoprolol on the heart measured by 24-hour holter monitoring.
    Withagen AJ; Corbeij HM; Huige MC; Kragten JA; Vermeulen A
    Drugs; 1989; 38 Suppl 2():67-9. PubMed ID: 2575985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
    Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
    Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy.
    Akhras F; Jackson G
    Drugs; 1989; 38 Suppl 2():28-34. PubMed ID: 2575977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of metoprolol on systolic time in patients with stable angina pectoris].
    Mosti G; Tomei G; Veltri M; Giusti C
    Minerva Cardioangiol; 1979 Mar; 27(3):147-52. PubMed ID: 37463
    [No Abstract]   [Full Text] [Related]  

  • 13. An overview of clinical trial experience with epanolol.
    Blake P
    Drugs; 1989; 38 Suppl 2():81-5. PubMed ID: 2575988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term effects of metoprolol and epanolol on tissue-type plasminogen activator and plasminogen activator inhibitor 1 in patients with ischaemic heart disease.
    Wright RA; Perrie AM; Stenhouse F; Alberti KG; Riemersma RA; MacGregor IR; Boon NA
    Eur J Clin Pharmacol; 1994; 46(3):279-82. PubMed ID: 7915237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of epanolol on quality of life.
    Jern S
    Drugs; 1989; 38 Suppl 2():71-4. PubMed ID: 2575987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of beta blockade with (epanolol) and without (atenolol) intrinsic sympathomimetic activity in stable angina pectoris. The Visacor Study Group.
    Boberg J; Larsen FF; Pehrsson SK
    Clin Cardiol; 1992 Aug; 15(8):591-5. PubMed ID: 1354086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of partial agonist activity on the side effects of beta-blockade in patients with chronic stable angina.
    Chambers J; Ong ML; Akhras F; Adam G; Jackson G
    Drugs; 1989; 38 Suppl 2():39-44. PubMed ID: 2575979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectoris.
    Comerford MB; Besterman EM
    Postgrad Med J; 1976 Aug; 52(610):481-6. PubMed ID: 10564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of epanolol in elderly patients with stable angina pectoris.
    Marlier R; McAinsh J; Cockshott ID
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):142-4. PubMed ID: 1970734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical use of the beta1-selective adrenoceptor blocker metoprolol in hypertension, angina pectoris and arrhythmias.
    Ann Clin Res; 1981; 13 Suppl 30():1-72. PubMed ID: 6117243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.